Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Sajeli Ahil Begum & Ahmed Kamal. (2023) What are the challenges involved in the strategies for future antibody-drug conjugate discovery and development for oncology?. Expert Opinion on Drug Discovery 18:6, pages 591-596.
Read now
Read now
Camille Martin, Claire Kizlik-Masson, André Pèlegrin, Hervé Watier, Marie-Claude Viaud-Massuard & Nicolas Joubert. (2018) Antibody-drug conjugates: Design and development for therapy and imaging in and beyond cancer, LabEx MAbImprove industrial workshop, July 27–28, 2017, Tours, France. mAbs 10:2, pages 210-221.
Read now
Read now
Jared L. Spidel, Earl F. Albone, Xin Cheng, Benjamin Vaessen, Sara Jacob, Andrew Z. Milinichik, Arielle Verdi, J. Bradford Kline & Luigi Grasso. (2017) Engineering humanized antibody framework sequences for optimal site-specific conjugation of cytotoxins. mAbs 9:6, pages 907-915.
Read now
Read now
Laia Montoliu-Gaya, Javier Murciano-Calles, Jose C. Martinez & Sandra Villegas. (2017) Towards the improvement in stability of an anti-Aβ single-chain variable fragment, scFv-h3D6, as a way to enhance its therapeutic potential. Amyloid 24:3, pages 167-175.
Read now
Read now
Earl F. Albone, Jared L. Spidel, Xin Cheng, Young Chul Park, Sara Jacob, Andrew Z. Milinichik, Ben Vaessen, Janet Butler, J. Bradford Kline & Luigi Grasso. (2017) Generation of therapeutic immunoconjugates via Residue-Specific Conjugation Technology (RESPECT) utilizing a native cysteine in the light chain framework of Oryctolagus cuniculus. Cancer Biology & Therapy 18:5, pages 347-357.
Read now
Read now
Sam Massa, Catarina Xavier, Serge Muyldermans & Nick Devoogdt. (2016) Emerging site-specific bioconjugation strategies for radioimmunotracer development. Expert Opinion on Drug Delivery 13:8, pages 1149-1163.
Read now
Read now
Articles from other publishers (50)
Ritwik Maiti, Bhumika Patel, Nrupesh Patel, Mehul Patel, Alkesh Patel & Nirav Dhanesha. (2023) Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities. Archives of Pharmacal Research 46:5, pages 361-388.
Crossref
Crossref
Yong Wang, Jingming Zhang, Boyang Han, Linzhi Tan, Wenkang Cai, Yuxuan Li, Yeyu Su, Yutong Yu, Xin Wang, Xiaojiang Duan, Haoyu Wang, Xiaomeng Shi, Jing Wang, Xing Yang & Tao Liu. (2023) Noncanonical amino acids as doubly bio-orthogonal handles for one-pot preparation of protein multiconjugates. Nature Communications 14:1.
Crossref
Crossref
Wenhui Liu & Shuqing Chen. 2023. Antibody-Drug Conjugates and Cellular Metabolic Dynamics. Antibody-Drug Conjugates and Cellular Metabolic Dynamics
55
68
.
Paolo Tarantino & Sara M. Tolaney. (2022) The Dawn of the Antibody–Drug Conjugates Era: How T-DM1 Reinvented the Future of Chemotherapy for Solid Tumors. Cancer Research 82:20, pages 3659-3661.
Crossref
Crossref
Hany E. Marei, Carlo Cenciarelli & Anwarul Hasan. (2022) Potential of antibody–drug conjugates (ADCs) for cancer therapy. Cancer Cell International 22:1.
Crossref
Crossref
Louis Jolivet, Imène Ait Mohamed Amar, Catherine Horiot, Fanny Boursin, Cyril Colas, Stéphanie Letast, Caroline Denevault-Sabourin, Emilie Allard-Vannier, Nicolas Joubert & Nicolas Aubrey. (2022) Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment–Drug Conjugates (FDCs). Pharmaceutics 14:8, pages 1524.
Crossref
Crossref
Chen-Fu Lo, Tai-Yu Chiu, Yu-Tzu Liu, Li-Rung Huang, Teng-Kuang Yeh, Kuan-Hsun Huang, Kuan-Liang Liu, Chia-Yu Hsu, Ming-Yu Fang, Yu-Chen Huang, Tsu-An Hsu, Chiung-Tong Chen & Lun Kelvin Tsou. (2022) Synthesis and Evaluation of Small Molecule Drug Conjugates Harnessing Thioester-Linked Maytansinoids. Pharmaceutics 14:7, pages 1316.
Crossref
Crossref
Pinky Shah & Sudeshna Chandra. (2022) Review on emergence of nanomaterial coatings in bio-engineered cardiovascular stents. Journal of Drug Delivery Science and Technology 70, pages 103224.
Crossref
Crossref
Shelby A. Fertal, Johanna E. Poterala, Suzanne M. Ponik & Kari B. Wisinski. (2022) Stromal Characteristics and Impact on New Therapies for Metastatic Triple-Negative Breast Cancer. Cancers 14:5, pages 1238.
Crossref
Crossref
Syeda Warisul Fatima & Sunil K. Khare. (2022) Benefits and challenges of antibody drug conjugates as novel form of chemotherapy. Journal of Controlled Release 341, pages 555-565.
Crossref
Crossref
Gunnar Houen. 2022. Therapeutic Antibodies. Therapeutic Antibodies
1
25
.
Joshua Z. Drago, Shanu Modi & Sarat Chandarlapaty. (2021) Unlocking the potential of antibody–drug conjugates for cancer therapy. Nature Reviews Clinical Oncology 18:6, pages 327-344.
Crossref
Crossref
Cecilie Knudsen, Jonas A. Jürgensen, Sofie Føns, Aleksander M. Haack, Rasmus U. W. Friis, Søren H. Dam, Sean P. Bush, Julian White & Andreas H. Laustsen. (2021) Snakebite Envenoming Diagnosis and Diagnostics. Frontiers in Immunology 12.
Crossref
Crossref
Donald J. AbrahamL. Nathan Tumey. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
39
.
Nicolas Joubert, Alain Beck, Charles Dumontet & Caroline Denevault-Sabourin. (2020) Antibody–Drug Conjugates: The Last Decade. Pharmaceuticals 13:9, pages 245.
Crossref
Crossref
Maryam Rahmati, Eduardo A. Silva, Janne E. Reseland, Catherine A. Heyward & Håvard J. Haugen. (2020) Biological responses to physicochemical properties of biomaterial surface. Chemical Society Reviews 49:15, pages 5178-5224.
Crossref
Crossref
Jittasak Khowsathit, Andrea Bazzoli, Hong Cheng & John Karanicolas. (2020) Computational Design of an Allosteric Antibody Switch by Deletion and Rescue of a Complex Structural Constellation. ACS Central Science 6:3, pages 390-403.
Crossref
Crossref
Kelvin K. Tsao, Ann C. Lee, Karl É. Racine & Jeffrey W. Keillor. (2020) Site-Specific Fluorogenic Protein Labelling Agent for Bioconjugation. Biomolecules 10:3, pages 369.
Crossref
Crossref
Puregmaa Khongorzul, Cai Jia Ling, Farhan Ullah Khan, Awais Ullah Ihsan & Juan Zhang. (2020) Antibody–Drug Conjugates: A Comprehensive Review. Molecular Cancer Research 18:1, pages 3-19.
Crossref
Crossref
L. Nathan Tumey. 2020. Antibody-Drug Conjugates. Antibody-Drug Conjugates
1
22
.
Alain Beck, Charles Dumontet & Nicolas Joubert. (2020) Les immunoconjugués en oncologie. médecine/sciences 35:12, pages 1043-1053.
Crossref
Crossref
Kanwen Yang, Bo Chen, Diego A. Gianolio, James E. Stefano, Michelle Busch, Charlene Manning, Kim Alving, Richard C. Gregory, William H. Brondyk, Robert J. Miller & Pradeep K. Dhal. (2019) Convergent synthesis of hydrophilic monomethyl dolastatin 10 based drug linkers for antibody–drug conjugation. Organic & Biomolecular Chemistry 17:35, pages 8115-8124.
Crossref
Crossref
Yu-Wei Liu, Yun-Yu Chen, Chia-Yu Hsu, Tai-Yu Chiu, Kuan-Liang Liu, Chen-Fu Lo, Ming-Yu Fang, Yu-Cheng Huang, Teng-Kuang Yeh, Koon Y. Pak, Brian D. Gray, Tsu-An Hsu, Kuan-Hsun Huang, Chuan Shih, Kak-Shan Shia, Chiung-Tong Chen & Lun K. Tsou. (2019) Linker Optimization and Therapeutic Evaluation of Phosphatidylserine-Targeting Zinc Dipicolylamine-based Drug Conjugates. Journal of Medicinal Chemistry 62:13, pages 6047-6062.
Crossref
Crossref
Wenhui Liu, Wenbin Zhao, Xuefei Bai, Shijie Jin, Yiming Li, Chixiao Qiu, Liqiang Pan, Ding Ding, Yingchun Xu, Zhan Zhou & Shuqing Chen. (2019) High antitumor activity of Sortase A-generated anti-CD20 antibody fragment drug conjugates. European Journal of Pharmaceutical Sciences 134, pages 81-92.
Crossref
Crossref
Hannes Merten, Jonas V. Schaefer, Fabian Brandl, Uwe Zangemeister-Wittke & Andreas Plückthun. 2019. Bioconjugation. Bioconjugation
253
273
.
Nicolas Aubrey, Emilie Allard-Vannier, Camille Martin, Francesca Bryden, Stéphanie Letast, Cyril Colas, Zineb Lakhrif, Nils Collinet, Isabelle Dimier-Poisson, Igor Chourpa, Marie-Claude Viaud-Massuard & Nicolas Joubert. (2018)
Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer
in Vitro
. Bioconjugate Chemistry 29:11, pages 3516-3521.
Crossref
Crossref
Frank-Jan Warnders, Marjolijn N. Lub-de Hooge, Elisabeth G. E. de Vries & Jos G. W. Kosterink. (2018) Influence of protein properties and protein modification on biodistribution and tumor uptake of anticancer antibodies, antibody derivatives, and non-Ig scaffolds. Medicinal Research Reviews 38:6, pages 1837-1873.
Crossref
Crossref
Raffaella Rossin, Ron M. Versteegen, Jeremy Wu, Alisher Khasanov, Hans J. Wessels, Erik J. Steenbergen, Wolter ten Hoeve, Henk M. Janssen, Arthur H. A. M. van Onzen, Peter J. Hudson & Marc S. Robillard. (2018) Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice. Nature Communications 9:1.
Crossref
Crossref
Hayley Pye, Mohammed Adil Butt, Laura Funnell, Halla W. Reinert, Ignazio Puccio, Saif U. Rehman Khan, Savvas Saouros, Jared S. Marklew, Ioanna Stamati, Maryam Qurashi, Rehan Haidry, Vinay Sehgal, Dahmane Oukrif, Michael Gandy, Hayley C. Whitaker, Manuel Rodriguez-Justo, Marco Novelli, Rifat Hamoudi, Gokhan Yahioglu, Mahendra P. Deonarain & Laurence B. Lovat. (2018) Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expression. Oncotarget 9:33, pages 22945-22959.
Crossref
Crossref
Christine E. Kaiser, Juan Pablo Rincon Pabon, Jittasak Khowsathit, M. Paola Castaldi, Steven L. Kazmirski, David D. Weis, Andrew X. Zhang & John Karanicolas. (2018) Modulating Antibody Structure and Function through Directed Mutations and Chemical Rescue. ACS Synthetic Biology 7:4, pages 1152-1162.
Crossref
Crossref
Mahendra Deonarain, Gokhan Yahioglu, Ioanna Stamati, Anja Pomowski, James Clarke, Bryan Edwards, Soraya Diez-Posada & Ashleigh Stewart. (2018) Small-Format Drug Conjugates: A Viable Alternative to ADCs for Solid Tumours?. Antibodies 7:2, pages 16.
Crossref
Crossref
I.B. O’Connor & J.G. Wall. 2018. Functionalised Cardiovascular Stents. Functionalised Cardiovascular Stents
319
341
.
Olivier Marcq. 2018. Innovations for Next-Generation Antibody-Drug Conjugates. Innovations for Next-Generation Antibody-Drug Conjugates
113
161
.
Yu-Wei Liu, Kak-Shan Shia, Chien-Huang Wu, Kuan-Liang Liu, Yu-Cheng Yeh, Chen-Fu Lo, Chiung-Tong Chen, Yun-Yu Chen, Teng-Kuang Yeh, Wei-Han Chen, Jiing-Jyh Jan, Yu-Chen Huang, Chen-Lung Huang, Ming-Yu Fang, Brian D. Gray, Koon Y. Pak, Tsu-An Hsu, Kuan-Hsun Huang & Lun K. Tsou. (2017) Targeting Tumor Associated Phosphatidylserine with New Zinc Dipicolylamine-Based Drug Conjugates. Bioconjugate Chemistry 28:7, pages 1878-1892.
Crossref
Crossref
Guhuan Liu, Guohai Shi, Haoyue Sheng, Yanyan Jiang, Haojun Liang & Shiyong Liu. (2017) Doubly Caged Linker for AND-Type Fluorogenic Construction of Protein/Antibody Bioconjugates and In Situ Quantification. Angewandte Chemie International Edition 56:30, pages 8686-8691.
Crossref
Crossref
Guhuan Liu, Guohai Shi, Haoyue Sheng, Yanyan Jiang, Haojun Liang & Shiyong Liu. (2017) Doubly Caged Linker for AND-Type Fluorogenic Construction of Protein/Antibody Bioconjugates and In Situ Quantification. Angewandte Chemie 129:30, pages 8812-8817.
Crossref
Crossref
Alain Beck, Liliane Goetsch, Charles Dumontet & Nathalie Corvaïa. (2017) Strategies and challenges for the next generation of antibody–drug conjugates. Nature Reviews Drug Discovery 16:5, pages 315-337.
Crossref
Crossref
ShinA Jang, Gyuhee Kim, Jihye Oh, Seungyeop Lee, Dongho Kim, Kook-Han Kim, Yong Ho Kim, Dong-Kwon Rhee & Sangho Lee. (2017) Molecular characterization of a single-chain antibody variable fragment (scFv) specific for PspA from Streptococcus pneumoniae. Biochemical and Biophysical Research Communications 482:1, pages 141-146.
Crossref
Crossref
B.C. Gomes. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
488
503
.
Dmitri Dormeshkin, Andrei Gilep, Gennady Sergeev & Sergey Usanov. (2016) Development of CYB5-fusion monitoring system for efficient periplasmic expression of multimeric proteins in Escherichia coli. Protein Expression and Purification 128, pages 60-66.
Crossref
Crossref
M. Stacey Ricci, R. Angelo De Claro & Natalie E. Simpson. 2016. Antibody-Drug Conjugates. Antibody-Drug Conjugates
267
284
.
H. Pye, M. A. Butt, H. W. Reinert, A. Maruani, J. P. M. Nunes, J. S. Marklew, M. Qurashi, L. Funnell, A. May, I. Stamati, R. Hamoudi, J. R. Baker, M. E. B. Smith, S. Caddick, M. P. Deonarain, G. Yahioglu, V. Chudasama & L. B. Lovat. (2016) A HER2 selective theranostic agent for surgical resection guidance and photodynamic therapy. Photochemical & Photobiological Sciences 15:10, pages 1227-1238.
Crossref
Crossref
Ray Bakhtiar. (2016) Antibody drug conjugates. Biotechnology Letters 38:10, pages 1655-1664.
Crossref
Crossref
Claire Ginn, Ji-won Choi & Steve Brocchini. (2016) Disulfide-bridging PEGylation during refolding for the more efficient production of modified proteins. Biotechnology Journal 11:8, pages 1088-1099.
Crossref
Crossref
Małgorzata A. Wronska, Iain B. O'Connor, Maura A. Tilbury, Akshay Srivastava & J. Gerard Wall. (2016) Adding Functions to Biomaterial Surfaces through Protein Incorporation. Advanced Materials 28:27, pages 5485-5508.
Crossref
Crossref
Kamila J. Pacholarz & Perdita E. Barran. (2016) Use of a charge reducing agent to enable intact mass analysis of cysteine-linked antibody-drug-conjugates by native mass spectrometry. EuPA Open Proteomics 11, pages 23-27.
Crossref
Crossref
Sujiet Puthenveetil, Sylvia Musto, Frank Loganzo, L. Nathan Tumey, Christopher J. O’Donnell & Edmund Graziani. (2016) Development of Solid-Phase Site-Specific Conjugation and Its Application toward Generation of Dual Labeled Antibody and Fab Drug Conjugates. Bioconjugate Chemistry 27:4, pages 1030-1039.
Crossref
Crossref
Taek-Chin Cheong, Mara Compagno & Roberto Chiarle. (2016) Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system. Nature Communications 7:1.
Crossref
Crossref
Hannes Merten, Fabian Brandl, Andreas Plückthun & Uwe Zangemeister-Wittke. (2015) Antibody–Drug Conjugates for Tumor Targeting—Novel Conjugation Chemistries and the Promise of non-IgG Binding Proteins. Bioconjugate Chemistry 26:11, pages 2176-2185.
Crossref
Crossref
Montserrat Carrasco-Triguero. (2015) Insights on the immunogenicity of antibody–drug conjugates. Bioanalysis 7:13, pages 1565-1568.
Crossref
Crossref